Fortress Biotech Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Revenue & cost
Revenue (Quarter)	0.15M	19.61M	58.49M	0.58M	18.23M	0.36M	-57.46M	12.16M	0.18M	0.18M	15.26M	13.03M	14.90M	14.63M	15.16M	13.14M	15.01M	17.63M	14.06M	18.72M
Cost of Revenue (Quarter)	7.48M	11.17M	9.53M	8.20M	7.63M	7.22M	7.72M	6.45M	7.77M	6.43M	2.25M	6.00M	5.73M	4.47M	4.68M	4.79M	4.94M	5.75M	5.44M	6.14M
Gross Profit (Quarter)	-7.33M	8.44M	48.96M	-7.63M	10.60M	-6.86M	-65.17M	5.72M	-7.58M	-6.25M	13.01M	7.03M	9.17M	10.16M	10.48M	8.35M	10.07M	11.88M	8.62M	12.57M
Operating items
Amortization - Intangibles (Quarter)												0.81M	0.81M	0.81M	0.96M	1.06M	1.06M	1.06M	1.11M	0.97M
Research & Development (Quarter)	22.83M	27.37M	43.05M	36.72M	33.13M	29.86M	34.49M	39.51M	32.14M	20.35M	14.04M	24.84M	12.67M	9.45M	9.69M	3.94M	8.13M	0.21M	-0.37M	0.81M
Selling, General & Administrative (Quarter)	19.38M	22.22M	27.70M	26.27M	29.05M	30.14M	28.20M	25.34M	24.44M	21.73M	19.47M	17.94M	20.82M	21.99M	26.86M	25.66M	38.76M	17.41M	14.73M	20.81M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	18.49M	21.42M	9.53M	8.20M	7.63M	7.27M	8.35M	6.45M	10.91M	1.40M	6.05M	6.82M	9.19M	5.29M	2.40M	5.86M	6.00M	6.82M	6.50M	7.11M
Operating Expenses (Quarter)	60.70M	71.01M	80.28M	71.19M	69.81M	67.26M	71.04M	71.30M	67.49M	48.51M	39.56M	49.60M	42.68M	36.72M	38.95M	35.46M	52.89M	24.44M	20.87M	28.72M
Operating Income (Quarter)	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	-4.79M	-10.01M
EBIT (Quarter)	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	-4.79M	-10.01M
Non-operating items
Interest & Investment Income (Quarter)	0.15M	0.13M	0.14M	0.14M	0.15M	0.42M	0.69M	1.04M	0.71M	0.55M	0.71M	0.83M	0.73M	0.59M	0.53M	0.49M	0.62M	0.74M	0.64M	1.58M
Other Non Operating Income (Quarter)	25.00M	8.38M	-39.29M			0.65M	-0.65M	0.30M	0.40M	0.62M	-1.35M	-0.02M	0.28M	1.07M	0.03M	-0.01M	27.13M	17.67M	-27.15M	10.74M
Non Operating Income (Quarter)	18.47M	4.06M	-6.03M	-2.21M	-3.00M	-2.33M	-2.36M	3.72M	-9.20M	3.17M	-8.99M	-2.46M	-1.04M	-4.53M	-2.14M	-2.37M	24.82M	15.66M	-1.42M	10.93M
Net income details
EBT (Quarter)	-45.47M	-54.23M	-59.38M	-49.48M	-53.93M	-53.06M	-57.00M	-62.13M	-55.81M	-10.58M	-28.61M	-38.34M	-29.18M	-26.62M	-25.98M	-25.28M	-39.06M	8.85M	-6.21M	0.92M
Tax Provisions (Quarter)			0.47M				0.45M			0.10M	0.36M			0.10M	0.34M			0.03M	-0.20M	0.32M
Profit After Tax (Quarter)	-24.39M	-45.86M	-31.57M	-15.80M	-21.40M	-53.06M	-57.45M	-21.54M	-59.30M	-10.72M	-28.98M	-39.02M	-10.95M	-26.69M	-26.32M	-10.58M	15.49M	5.85M	34.33M	0.60M
Income from Non-Controlling Interests (Quarter)	20.86M	-25.08M	36.94M	-33.72M	-32.57M	-30.55M	-224.18M	33.61M	34.52M	-5.68M	19.70M	23.61M	-17.88M	-13.83M	-19.55M	14.11M	-27.14M	-2.98M	-78.00M	-1.07M
Income from Continuing Operations (Quarter)	-45.47M	-54.23M	-59.85M	-49.48M	-53.93M	-53.06M	-57.45M	-62.13M	-55.81M	-10.68M	-28.96M	-38.34M	-29.18M	-26.73M	-26.32M	-25.28M	-39.06M	8.83M	-6.01M	0.60M
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)	-45.47M	-54.23M	-59.85M	-49.48M	-53.93M	-53.06M	-57.45M	-62.13M	-55.81M	-10.68M	-28.96M	-38.34M	-29.18M	-26.73M	-26.32M	-25.28M	-39.06M	8.83M	-6.01M	0.60M
Income towards Parent Company (Quarter)	-45.47M	-54.23M	-59.85M	-49.48M	-53.93M	-53.06M	-57.45M	-62.13M	-55.81M	-10.68M	-28.96M	-38.34M	-29.18M	-26.73M	-26.32M	-25.28M	-39.06M	8.83M	-6.01M	0.60M
Preferred Dividend Payments (Quarter)					2.01M	2.01M	2.01M		2.00M	2.01M	2.01M	2.44M		2.17M	2.89M	2.13M		2.17M	2.26M	2.01M
Net Income towards Common Stockholders (Quarter)	-45.47M	-54.23M	-59.85M	-49.48M	-23.36M	-24.52M	-28.96M	-23.55M	-26.92M	-7.05M	-11.29M	-17.86M	-13.34M	-15.04M	-9.65M	-12.71M	13.36M	3.67M	-6.20M	-2.48M
Additional items
EPS (Basic) (Quarter)	-8.42	-10.00	-10.99	-8.60	-3.95	-4.11	-4.89	-3.47	-3.65	-0.94	-1.39	-1.04	-0.73	-0.76	-0.46	-0.48	0.50	0.13	-0.22	-0.08
EPS (Diluted) (Quarter)	-8.42	-10.00	-10.99	-8.60	-3.95	-4.11	-4.89	-3.47	-3.65	-0.94	-1.39	-1.04	-0.73	-0.76	-0.46	-0.48	0.45	0.11	-0.22	-0.08
Shares Outstanding (Quarter)	5.40M	5.42M	5.45M	5.75M	5.92M	5.96M	5.93M	6.79M	7.38M	7.50M	8.11M	17.15M	18.32M	19.70M	20.78M	26.45M	26.88M	27.24M	27.90M	31.79M
Shares Outstanding (Diluted) (Quarter)	5.40M	5.42M	5.45M	5.75M	5.92M	5.96M	5.93M	6.79M	7.38M	7.50M	8.11M	17.15M	18.32M	19.70M	20.78M	26.45M	29.82M	33.10M	27.90M	31.79M
Shares Outstanding (Entity) (Quarter)	5.40M	5.42M	5.45M	5.75M	5.92M	5.96M	5.93M	6.79M	8.78M	8.94M	8.11M	19.38M	18.32M	19.70M	20.78M	29.55M	29.75M	31.01M	31.36M	33.31M
EBITDA (Quarter)	-42.86M	-49.92M	-62.00M	-47.27M	-50.93M	-50.73M	-54.63M	-58.87M	-50.10M	-13.76M	-19.61M	-36.57M	-27.79M	-22.09M	-23.84M	-22.32M	-36.47M	-6.81M	-4.79M	-10.01M
Interest Expenses (Quarter)	2.76M	4.44M	-2.48M	2.35M	3.15M	3.39M	0.52M	4.30M	6.42M	2.53M	2.06M	2.60M	2.12M	6.21M	6.19M	3.45M	3.21M	2.74M	3.03M	16.03M
Tax Rate (Quarter)			-0.80%				-0.79%			-0.94%	-1.25%			-0.38%	-1.29%			0.29%	3.22%	34.71%

Research Tools

Datasets

Plans

Developers

Fortress Biotech FBIOP Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Fortress Biotech FBIOP Income Statement (2010-2026)

Create an account

Sign In

Reset Password